Halozyme Therapeutics
HALO
#2005
Rank
S$10.39 B
Marketcap
$82.05
Share price
1.11%
Change (1 day)
53.43%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of June 2024 : S$0.37 B

According to Halozyme Therapeutics's latest financial reports the company has S$0.37 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$0.11 B-51.38%
2022-12-31$S$0.22 B-14.3%
2021-12-31$S$0.26 B33.01%
2020-12-31$S$0.19 B61.83%
2019-12-31$S$0.12 B-63.6%
2018-12-31$S$0.33 B21.66%
2017-12-31$S$0.27 B-692.83%
2016-12-31$-S$47.01 M-177.22%
2015-12-31$S$60.87 M11.42%
2014-12-31$S$54.63 M-315.69%
2013-12-31$-S$25.34 M-142.37%
2012-12-31$S$59.78 M323.5%
2011-12-31$S$14.11 M-46.18%
2010-12-31$S$26.22 M170.34%
2009-12-31$S$9.7 M-56.14%
2008-12-31$S$22.11 M-73.52%
2007-12-31$S$83.52 M136%
2006-12-31$S$35.39 M16.75%
2005-12-31$S$30.31 M38.68%
2004-12-31$S$21.85 M3335.91%
2003-12-31$S$0.63 M-196.6%
2002-12-31$-S$0.66 M-1657.78%
2001-12-31$S$0.04 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-S$0.3 B-178.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.76 B 4,611.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.03 B 2,563.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$114.59 B 30,296.58%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.92 B 26,937.01%๐Ÿ‡ซ๐Ÿ‡ท France
S$93.18 B 24,617.37%๐Ÿ‡บ๐Ÿ‡ธ USA